Discontinued — last reported Q2 '18
Non-Current Liabilities
Transition Tax Liability for Accumulated Foreign Earnings
Pfizer Transition Tax Liability for Accumulated Foreign Earnings remained flat by 0.0% to $15.00B in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $15.00B to $15.00B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2017
Last reportedQ2 2018
How to read this metric
A steady decrease indicates the company is successfully paying down this specific tax obligation according to the statutory schedule.
Detailed definition
This represents the remaining long-term liability associated with the one-time transition tax on accumulated foreign ear...
Peer comparison
Specific to US-based multinational corporations affected by the 2017 tax reform.
Metric ID:
transition_tax_liability_foreign_earningsHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B | $15.00B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$15.00B – $15.00B
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak13+ quarters growth
Transition Tax Liability for Accumulated Foreign Earnings at Other Companies
Frequently Asked Questions
- What is Pfizer's transition tax liability for accumulated foreign earnings?
- Pfizer (PFE) reported transition tax liability for accumulated foreign earnings of $15.00B in Q3 2025.
- How has Pfizer's transition tax liability for accumulated foreign earnings changed year-over-year?
- Pfizer's transition tax liability for accumulated foreign earnings decreased by 0.0% year-over-year, from $15.00B to $15.00B.
- What does transition tax liability for accumulated foreign earnings mean?
- The remaining portion of a one-time tax bill on past foreign profits, payable over several years.